EN
instrument_fundamentals
| date | Close | change | Change (%) | instr__open | High | Low |
|---|
instr__news
Assessing BioNTech (BNTX) Valuation After Goldman Sachs Buy Upgrade And Oncology Growth Focus
BioNTech (NASDAQ:BNTX) Rating Lowered to Market Perform at Leerink Partners
Africa's deep tech boom rests on a fragile research ecosystem
Lingohr Asset Management GmbH Acquires 40,821 Shares of BioNTech SE Sponsored ADR $BNTX
Privium Fund Management B.V. Acquires 8,013 Shares of BioNTech SE Sponsored ADR $BNTX
BioNTech SE Sponsored ADR $BNTX Shares Purchased by Lingohr Asset Management GmbH - Daily Political
BioNTech (NASDAQ:BNTX) vs. uniQure (NASDAQ:QURE) Critical Analysis - Daily Political
Goldman Sachs Highlights BioNTech's (BNTX) Immuno-Oncology and ADC Pipeline
BioNTech Advances Oncology Focus With BNT324 Trial And Leadership Shift
Appointments and advancements for Jan. 29, 2026 | BioWorld
BioNTech SE (BNTX): A Bull Case Theory
BioNTech SE's (NASDAQ:BNTX) Price Is Right But Growth Is Lacking After Shares Rocket 26% - Simply Wall St News
Is BioNTech (BNTX) Pricing Reflect Its mRNA Pipeline Potential After Recent Share Price Gains
BioNTech Shares Surge in 2026 as Analysts See Further Upside
Lbp Am Sa Acquires 47,859 Shares of BioNTech SE Sponsored ADR $BNTX - Zolmax
BioNTech SE Sponsored ADR $BNTX Holdings Boosted by Lbp Am Sa
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Sector Gamma AS Has $2.74 Million Holdings in BioNTech SE Sponsored ADR $BNTX
BioNTech (BNTX) Is Up 6.4% After Expanding Late-Stage Oncology Pipeline Ambitions - Has The Bull Case Changed?
Baillie Gifford & Co. Lowers Position in BioNTech SE Sponsored ADR $BNTX
BioNTech (NASDAQ:BNTX) Earns Buy Rating from Berenberg Bank
US Stock Market Today: S&P 500 Futures Rise On Cooling Inflation And Housing Jitters - Simply Wall St News
BioNTech (BNTX) Valuation Check After Recent Share Price Momentum And Ongoing Net Loss
BioNTech (NASDAQ:BNTX) Trading 7.5% Higher - Here's Why
The Stock Market Is Closed on MLK Day, but Here's What Goldman Sachs Says to Buy When Trading Resumes | Markets Insider
BioNTech (BNTX) Is Up 7.3% After Unveiling Ambitious Late-Stage Oncology Pipeline Expansion
SG Americas Securities LLC Sells 69,726 Shares of BioNTech SE Sponsored ADR $BNTX - Markets Daily
A Look At BioNTech (BNTX) Valuation After Expanded Oncology Pipeline Update
BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan
Big Pharma turf war erupts: Bayer sues vaccine makers over alleged stolen mRNA technology - NaturalNews.com
Monsanto Sues COVID-19 Vaccine Manufacturers, Alleging Copyright Infringement | ZeroHedge
Pancreatic cancer: advances in immunology, translational analyses and therapeutic paradigms
BioNTech (BNTX) Is Up 5.1% After 90%-Effective COVID Data Raises New Franchise Questions
Bayer sues Pfizer, Moderna, J&J and BioNTech over alleged Covid vaccine patent breach | Malay Mail
Bayer sues Covid-jab makers, alleging patent violation
Bayer's Monsanto Files Lawsuit Against Pfizer, BioNTech, and Moderna Over mRNA Patent Infringement, ETPharma
BioNTech (NasdaqGS:BNTX) Valuation Check After Positive COVID 19 Vaccine Efficacy Data
